ABOUT OCI
ABOUT PMH
ABOUT PMHF
ABOUT UHN
ABOUT US
Overview
Background
The need
Scope of Research
The Next 5 Years
One of the Top 5
A World Leader
Accountability & Governance
OUR RESEARCH
Overview
Team
Focus
Highlights
Honour Roll
Ask a Question
Breast Cancer Research
DONATE
Donate Now
Ways to Help
OUR STORIES
Featured stories
LATEST NEWS
MEDIA ROOM
Overview
Press Releases
CFCRI in the News
Publications
Image Gallery
Contact
WHAT'S ON
CONTACT US
Overview
Team
Dr. Tak Mak
Dr. David Jaffray
Dr. Malcolm Moore
Dr. John Dick
Dr. Pamela Ohashi
Dr. Frances Shepherd
Dr. Ming Tsao
Dr. Norman Boyd
Dr. Mark Clemons
Dr. Aaron Schimmer
Dr. Robert Bristow
Dr. Laura Dawson
Focus
Highlights
Honour Roll
Ask a Question
Breast Cancer Research
Dr. Laura Dawson
Treatment of liver cancer
Dr. Dawson’s lab focuses on the development of high precision radiation techniques that allow radiation to be investigated for tumours previously unsuitable for radiotherapy due to proximity to critical adjacent normal tissues.
An example is primary and metastatic liver cancer, a site where local therapy with surgery has the potential to cure patients, but the majority of patients are inoperable. A phase I/II study of hypofractionated high precision radiotherapy for patients with liver cancer is open, where toxicities and benefits of such treatment are being investigated. The treatment protocol involves the use of high precision intensity modulated radiation, image guidance and breath hold radiation to minimize liver motion due to breathing.
The role of kV cone beam CT for image guidance is being investigated, as are new methods of describing normal tissue complication probability following radiotherapy.
You have an old version of Adobe's Flash Player.
Get the latest Flash player
.